February 27, 2025 marks the first day of the 23rd Regulatory Affairs Conference in Amsterdam, organised by Medicines for Europe, and our Billev Pharma East team is already actively participating in the workshops of the two-day event.

Katja Pečjak Reven and Aljaž Grlica will be attending key sessions where they will be engaging with regulatory experts and exchanging views on topics such as environmental risk assessment (ERA), electronic product information (ePI), the digitalization of regulatory processes, the role of artificial intelligence (AI) and real-world evidence (RWE), as well as planned revisions of the EU pharmaceutical regulation, variation and submission changes. 

Our active involvement in these discussions is central to our company’s efforts to pursue new opportunities and, through active contribution, help shape the future of the pharmaceutical industry.

For more information and RAC25 programme, visit https://www.medicinesforeurope.com/events/rac25/.